Home

OLIVER FETZER

CIK 1219018 · Senior Vice President · last filed 2022-03-11

OLIVER FETZER is a Senior Vice President who has filed 44 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ARNA, was dated Mar 11, 2022. Across all open-market trades the lifetime net is −$3.5M, making them a net seller over the disclosed history. 24 SEC filings were submitted jointly with CUBIST PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

44

Lifetime Open-Market Net

-$3.52M

Filer Profile

Reported Address
AUXILIUM PHARMACEUTICALS, INC.
40 VALLEY STREAM PARKWAY
MALVERN, PA 19355
Related Filers
CUBIST PHARMACEUTICALS INC — 24 joint filings, latest 2007-09-17
ARENA PHARMACEUTICALS INC — 8 joint filings, latest 2022-03-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARENA PHARMACEUTICALS INC (ARNA) Delisted Director 8,167 $99.99 $816.6K -$85.2K 7 2022-03-11
AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted Director 0 — — -$3.44M 33 2015-01-30
CUBIST PHARMACEUTICALS INC (CBST) Delisted Senior Vice President 3,567 — — $0 4 2007-08-24

Recent Filings

44 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-03-11 ARENA PHARMACEUTICALS INC (ARNA) Delisted Mixed −9,692 $0 EDGAR
2021-06-15 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) +3,067 $0 EDGAR
2020-06-16 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) +2,446 $0 EDGAR
2019-06-17 ARENA PHARMACEUTICALS INC (ARNA) Delisted Mixed +1,129 -$85.2K EDGAR
2018-06-15 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) +3,050 $0 EDGAR
2017-06-14 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) — $0 EDGAR
2017-02-14 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) — $0 EDGAR
2015-01-30 AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted Other (J) −19,197 -$365.3K EDGAR
2014-12-04 AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted Mixed — -$1.61M EDGAR
2013-08-15 AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted Sell (S) −1,900 -$35.6K EDGAR
Showing 1–10 of 44
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.